Related Experiment Video
Updated: Dec 15, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Interplay between Cellular and Molecular Mechanisms Underlying Inflammatory Bowel Diseases Development-A Focus on
Iuliana Samoilă1, Sorina Dinescu1,2, Marieta Costache1,2
1Department of Biochemistry and Molecular Biology, University of Bucharest, 050095 Bucharest, Romania.
Inflammatory bowel diseases (IBD) involve continuous gastrointestinal inflammation. This review details how inflammasome activation and non-coding RNAs contribute to ulcerative colitis pathogenesis.
Area of Science:
- Gastroenterology
- Immunology
- Molecular Biology
Background:
- Inflammatory bowel diseases (IBD) are characterized by chronic gastrointestinal inflammation.
- Increased intestinal pathogens trigger inflammasome assembly, a key immune response.
- While protective, excessive inflammasome activation, particularly NLRP3, drives pro-inflammatory cytokine production.
Purpose of the Study:
- To review the cellular and molecular mechanisms driving inflammation in ulcerative colitis (UC).
- To elucidate the role of inflammasome activation and non-coding RNAs in IBD pathogenesis.
Main Methods:
- Literature review of cellular and molecular mechanisms in UC.
- Analysis of inflammasome pathways, autophagy, unfolded protein response, and non-coding RNAs (miRNAs, lncRNAs).
Main Results:
- Excessive nucleotide-binding oligomerization domain-like receptor and pyrin domain-containing protein 3 (NLRP3) inflammasome assembly leads to high pro-inflammatory cytokine synthesis.
- Autophagy and unfolded protein response pathways are activated to restore homeostasis.
- Aberrant expression of microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) significantly impacts IBD mechanisms.
Conclusions:
- Understanding these pathways is crucial for IBD management.
- Targeting inflammasomes and non-coding RNAs may offer therapeutic strategies for UC.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

